Mochi Health cuts compounded semaglutide price to $60 a month
The telehealth provider moved to dose-based pricing and added an in-platform blood testing service covering A1C, cholesterol and thyroid markers.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 18 07:03 ETSource: USA Today
The wire
- 01Mochi Health says compounded semaglutide now starts at $60 per month and compounded tirzepatide at $90 per month under dose-based pricing, with membership from $49 annually or $79 first month.
- 02Compounded GLP-1 pricing below brand list levels keeps pressure on telehealth competitors and on pharmacies weighing demand for non-FDA-approved compounded incretins.
- 03Mochi Labs is unavailable in New York, New Jersey, Rhode Island and Hawaii, and the pricing and savings claims come from the company itself.
From the source
Read at usatoday.comLower GLP-1 costs are here. Mochi cuts prices and adds lab testing
GLP-1 weight loss treatment just got more affordable for some patients. Mochi Health has lowered prices on compounded semaglutide and compounded tirzepatide while launching a new lab-testing service that lets members monitor key health markers without leaving the platform.
